Browsing Tag
DB-1303
2 posts
Is BioNTech finally breaking out of its COVID shadow? The case for its oncology comeback
Discover how BioNTech is transforming from COVID-19 pioneer to oncology powerhouse, led by ADC success and mRNA innovations. Read more now.
BioNTech stock jumps 8.66% after DB-1303 meets primary endpoint in breast cancer trial
BioNTech stock surged after DB-1303 met its Phase 3 endpoint in HER2-positive breast cancer. Find out what this means for global oncology strategy.